Regulation/Legislation (Health)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Regulation
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Regulation
Valisure Will Continue As 'Inconvenient' Reminder For Change To US Drug Quality ‘Status Quo’
“I think the symptoms of the core disease of quality is not having an independent layer or just not being able to invest more in quality or whatever the other root causes of addressing these quality issues,” says analytical lab president David Light.
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
US FDA Wants Advisory Committee Duty To Be ‘Enjoyable’
Advisory committee reform efforts include streamlining the selection and onboarding processes, in part to understand that members often have other professional priorities, Principal Deputy Commissioner Namandjé Bumpus said.
Legislation
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Legislation
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
Biden Administration's $7.13Bn FDA Budget Request For FY2025 Includes $3.3Bn In User Fees
White House’s 1,298-page budget request published on 11 March includes around $2m more than the agency’s total FY2024 spending Congress approved on 8 March and the president signed the next day. Of FDA’s total FY2025 spending $3.286bn would come from user fees.
FDA Food Programs Chief Assured On Supplement Office Move, Pessimistic On Agency Budget
“We think that this structure actually provides us the best path forward in terms of optimizing on our resources,” Jim Jones says of ODSP move. On the other hand, he says Congress didn’t appropriate for the agency’s optimal operation.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.